Trial Site Detail
Drug: |
Imatinib + Bevacizumab |
|||
|---|---|---|---|---|
Trial: |
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Geisinger Clinical & Medical Center - CCOP100 N. Academy Ave. |
Principal Investigator: |
Albert M. Bernath, MD |
|---|---|
Contact: |
570-271-6413 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Geisinger Clinical & Medical Center - CCOP Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.